Product Code: ETC6185084 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Closely aligned with implants, the micro invasive glaucoma surgery (MIGS) devices market in Australia is being shaped by the rising trend toward less invasive ophthalmic interventions. Ophthalmologists are turning to MIGS devices as alternatives to traditional surgeries, especially in combination with cataract procedures. Continued investment in research and patient education is expected to drive this market segment further.
In Australia, the micro invasive glaucoma surgery (MIGS) devices market is witnessing expansion as ophthalmologists adopt less traumatic and highly effective procedures for glaucoma management. Advancements in device technology, including stents and shunts, are facilitating minimally invasive techniques. The trend is reinforced by patient preference for outpatient surgeries and quicker post-operative recovery.
The market for micro invasive glaucoma surgery (MIGS) devices is constrained by both clinical and commercial challenges. While the minimally invasive nature of MIGS appeals to patients, its adoption is slowed by skepticism regarding long-term efficacy compared to traditional methods. Regulatory scrutiny, reimbursement issues, and a limited pool of glaucoma specialists trained in MIGS techniques create hurdles for widespread adoption. Furthermore, the relatively small patient base in Australia impacts the commercial viability of introducing new devices.
As demand for minimally invasive glaucoma surgery devices rises, theres significant opportunity for investors to support companies developing novel stents, shunts, and handheld surgical instruments. Private equity and venture capital can play a role in scaling production, gaining regulatory approvals, and expanding into international markets through strategic partnerships.
The governments healthcare policies have a direct impact on the micro invasive glaucoma surgery devices market, particularly through the regulation of medical devices by the TGA. Stringent regulatory requirements ensure that only safe and effective devices are allowed in the market, but they also add significant costs and time to the development process. Additionally, the reimbursement policies surrounding glaucoma surgeries, including micro-invasive techniques, influence market adoption. While Medicares coverage for traditional glaucoma treatments is robust, there is often hesitancy to reimburse newer, more specialized devices without extensive clinical data, posing a challenge for market growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Micro Invasive Glaucoma Surgery Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Micro Invasive Glaucoma Surgery Devices Market - Industry Life Cycle |
3.4 Australia Micro Invasive Glaucoma Surgery Devices Market - Porter's Five Forces |
3.5 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Micro Invasive Glaucoma Surgery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Micro Invasive Glaucoma Surgery Devices Market Trends |
6 Australia Micro Invasive Glaucoma Surgery Devices Market, By Types |
6.1 Australia Micro Invasive Glaucoma Surgery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By MIGS Stents, 2021- 2031F |
6.1.4 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By MIGS Shunts, 2021- 2031F |
6.1.5 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Micro Invasive Glaucoma Surgery Devices Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Hospital Outpatient Departments, 2021- 2031F |
6.2.3 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Ophthalmology Clinics, 2021- 2031F |
6.2.4 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Ambulatory Surgery Centers, 2021- 2031F |
6.2.5 Australia Micro Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Micro Invasive Glaucoma Surgery Devices Market Import-Export Trade Statistics |
7.1 Australia Micro Invasive Glaucoma Surgery Devices Market Export to Major Countries |
7.2 Australia Micro Invasive Glaucoma Surgery Devices Market Imports from Major Countries |
8 Australia Micro Invasive Glaucoma Surgery Devices Market Key Performance Indicators |
9 Australia Micro Invasive Glaucoma Surgery Devices Market - Opportunity Assessment |
9.1 Australia Micro Invasive Glaucoma Surgery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Micro Invasive Glaucoma Surgery Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Micro Invasive Glaucoma Surgery Devices Market - Competitive Landscape |
10.1 Australia Micro Invasive Glaucoma Surgery Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Micro Invasive Glaucoma Surgery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |